Detailed Study of High Content Screening Market by Research Cosmos
High Content Screening Market Size and Growth Rate:
According to the latest reports published by Research Cosmos, High Content Screening Market was projected to reach USD 829.0 Million by 2022 growing at a CAGR of 9.6% during the forecast period 2018 to 2022.
Browse details of 154 number of pages research report developed on High Content Screening Market @ https://www.researchcosmos.com/reports/global-high-content-screening-market-analysis-and-forecast-to-2022-growth-opportunity-assessment/2772163
High Content Screening Market Growth Drivers and Restraints:
The factors anticipated to drive the growth of the high content screening (HCS) market throughout the forecast period are growing need for price containment in pharmaceutical R&D, increase in funding for cellular analysis, and technological progress in HCS solutions. The growing number of compact research organizations giving HCS outsourcing help and application in personalized drug offer significant growth possibilities in the global market. The growing adoption of label-free technologies and increasing focus on stem cell study are important trends in the HCS market.
Government is taking actions to encourage research related to medicines and biotechnology. Such factors are expected to impact the global high content screening market absolutely till 2025. Economics of the high–end and mid–end screening devices are expected to contribute towards the global business growth by the end of 2024. Moreover, the growing focus on secondary screening of multiple cells for reading toxicity cases is predicted to rev up the adoption of special content screening system in the global market. Additionally, increasing need to assess risks associated with chronic diseases is supposed to boost market demand. Such circumstances are expected to provide significantly towards the global market boom during the projected period.
Some of the major applications of HCS include primary & secondary screening, aggregate profiling, and target description & validation. The research companies, pharmaceutical & biotechnology firms and academic and analysis institutes are the prominent end-users of this market. As of 2014, the high screening instrument section held a substantial share in the global business, owing to the need for high cost-efficient alternatives. The cost-effectiveness is resultant from the use of features such as LED light generators that reduces the intensity changes and reduces the need for switching onto surface illuminating sources. The content screening software division is expected to be the quickest growing segment over the projection period owing to comments like confocal imaging and natural workflow interface.
Geographical Analysis of High Content Screening Market:
North America accounted for the highest share of the high content screening market, owing to important growth factors including rising incidences of chronic diseases, rising predominance of the geriatric population, many collaborations with research institutes, high disposable earnings and advanced healthcare infrastructure. Furthermore, the increasing number of mergers & acquisitions and raised awareness also moved the market growth in this region. The Asia Pacific is expected to be the quickest growing market over the projected period as a consequence of leading factors such as increasing disposable income, the rising need of novel drugs, improving patient awareness about the technologies integrated with developing healthcare infrastructure.
Ask For Free Sample of the report @ https://www.researchcosmos.com/request/global-high-content-screening-market-analysis-and-forecast-to-2022-growth-opportunity-assessment/2772163
Key Players of High Content Screening Market:
Main players of high content screening market are Molecular Devices, PerkinElmer Inc., Thermo Fisher Scientific, GE Healthcare, Becton, Merck KGaA, Dickinson and Company, Thorlabs, Inc., Cell Signaling Technology, Genedata AG and Yokogawa Electric Corporation.
High Content Screening Market Segmentation:
By Product:
- Instruments
- Consumables
- Software
- Services
- Accessories
By Application:
- Primary and Secondary Screening
- Target Identification and Validation
- Toxicity Studies
- Compound Profiling
By End User:
- Pharmaceutical and Biotechnology Companies
- Academic and Government Institutes
- Contract Research Organizations
By Region:
- North America
- South America
- Europe
- Asia Pacific
- Middle East and Africa
For any queries, inquire more @ https://www.researchcosmos.com/inquire/global-high-content-screening-market-analysis-and-forecast-to-2022-growth-opportunity-assessment/2772163
About Us:
Research Cosmos is a provider of standard and customized market research, business intelligence and consulting services across more than 100 domains in different industries of the world. We host the trending market reports of the world’s top-notch publishing companies, offering services to a wide range of customers from students to fortune 500 companies and discloses the hidden opportunities in every leading industry of the world.
Contact:
Kevin Stewart
Global Sales Manager
Research Cosmos